AP
NEO icon

Archon Partners’s NeoGenomics NEO Stock Holding History

Archon Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,100
Closed -$1.21M – 58
2021
Q3 		$1.21M Sell
25,100
-2,900
-10% -$134K 0.15% 49
2021
Q2 		$1.26M Buy
28,000
+6,100
+28% +$270K 0.16% 52
2021
Q1 		$1.06M Buy
21,900
+2,900
+15% +$151K 0.15% 51
2020
Q4 		$1.02M Buy
+19,000
New +$859K 0.14% 51

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Archon Partners's NEO Position: Q4 2021 in Review

Archon Partners sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 25,100 shares — an estimated $1.21M sold.

Archon Partners first reported a position in NEO in Q4 2020 and held it in 4 quarters. The position peaked at $1.26M in Q2 2021. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Archon Partners reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Archon Partners sold 25,100 NeoGenomics shares in Q4 2021, an estimated $1.21M.
  • Archon Partners first reported a position in NeoGenomics in Q4 2020 and held it in 4 quarters.
  • Archon Partners's NeoGenomics position peaked at $1.26M in Q2 2021.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Archon Partners's 13F filing for Q4 2021, filed 14 Feb 2022.